Page 110

110

retiring this measure noted that removing it would help focus the overall measure set on outcomes measures and reduce reporting burden, while other commenters thought this was an important measure to retain for consumers and plans. There was mixed reaction to removing the SNP-specific measures, such as the Care for Older Adults measures. Some commenters supported keeping the Care for Older Adults measures in the Star Ratings due to their importance for enrollees in SNPs, in particular for I-SNP enrollees, while other commenters noted removing these measures would help reduce burden. We will take these comments into consideration as we contemplate proposing future changes to the measures. Any changes to the measure set would need to be proposed and finalized through the rulemaking process. Statin Therapy for Patients With Cardiovascular Disease (Part C). NCQA is reevaluating this measure for the 2026 measurement year. First introduced for the 2015 measurement year, it assesses whether patients with atherosclerotic cardiovascular disease (ASCVD) received appropriate statin therapy and achieved a medication adherence rate of 80 percent. The adherence rate for this measure is not part of the Star Ratings program. Based on a review of recent literature and clinical guidelines, as well as preliminary input from the Cardiovascular Measurement Advisory Panel, NCQA is considering modifying the measure’s age ranges and denominator inclusion and exclusion criteria. NCQA is considering removing the existing sex- specific age bands and increasing the upper age limit. NCQA is also examining the current value sets and method used to identify members with ASCVD for any potential updates, as well as evaluating the potential for transitioning this measure to the electronic clinical data systems (ECDS)-reporting method. Changes made to this measure that expand the eligible population would be considered a substantive change. As codified at § 422.164(d)(2), a measure with substantive specification changes must be added or updated through rulemaking and must remain on the display page for at least two years prior to becoming a Star Ratings measure. The majority of commenters supported the potential changes to this measure; however, there was mixed feedback regarding the age band adjustments, the inclusion and exclusion criteria, and the transition to ECDS-reporting. We have shared this feedback with NCQA for their consideration. Transitions of Care (Part C). NCQA is reevaluating the Transitions of Care measure, which includes four indicators related to care coordination after a patient is discharged from an inpatient setting to home. The first two indicators relate to notification of inpatient admission and receipt of discharge information and currently use the hybrid reporting method only. The second two indicators, patient engagement after discharge and medication reconciliation, utilize hybrid and administrative reporting methods. NCQA intends to develop a new ECDS-reported version of the measure that will also consider changes from the current specification based on expert feedback and testing. NCQA plans to conduct measure testing in 2025 and implement the new ECDS-reported measure for the 2027 measurement year. NCQA plans to maintain the current Transitions of Care measure alongside the new measure for a period of time to allow for transition to the new measure. If the changes are substantive, we would keep the legacy measure